Human Genome Epidemiology Literature Finder
Records 1 - 19 (of 19 Records) |
Query Trace: Ovarian Neoplasms and CCNE1[original query] |
---|
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer research 2007 Apr 67 (7): 3027-35. Gayther Simon A, Song Honglin, Ramus Susan J, Kjaer Susan Krüger, Whittemore Alice S, Quaye Lydia, Tyrer Jonathan, Shadforth Danielle, Hogdall Estrid, Hogdall Claus, Blaeker Jan, DiCioccio Richard, McGuire Valerie, Webb Penelope M, Beesley Jonathan, Green Adele C, Whiteman David C, , Goodman Marc T, Lurie Galina, Carney Michael E, Modugno Francesmary, Ness Roberta B, Edwards Robert P, Moysich Kirsten B, Goode Ellen L, Couch Fergus J, Cunningham Julie M, Sellers Thomas A, Wu Anna H, Pike Malcolm C, Iversen Edwin S, Marks Jeffrey R, Garcia-Closas Montserrat, Brinton Louise, Lissowska Jolanta, Peplonska Beata, Easton Douglas F, Jacobs Ian, Ponder Bruce A J, Schildkraut Joellen, Pearce C Leigh, Chenevix-Trench Georgia, Berchuck Andrew, Pharoah Paul D P, |
Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Feb 14 (4): 1090-5. Song Honglin, Hogdall Estrid, Ramus Susan J, Dicioccio Richard A, Hogdall Claus, Quaye Lydia, McGuire Valerie, Whittemore Alice S, Shah Mitul, Greenberg David, Easton Douglas F, Kjaer Susanne Kruger, Pharoah Paul D P, Gayther Simon |
Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Mar 18 (3): 935-44. Goode Ellen L, Fridley Brooke L, Vierkant Robert A, Cunningham Julie M, Phelan Catherine M, Anderson Stephanie, Rider David N, White Kristin L, Pankratz V Shane, Song Honglin, Hogdall Estrid, Kjaer Susanne K, Whittemore Alice S, DiCioccio Richard, Ramus Susan J, Gayther Simon A, Schildkraut Joellen M, Pharaoh Paul P D, Sellers Thomas |
Integrated genomic analyses of ovarian carcinoma. Nature 2011 Jun 474 (7353): 609-15. Authors are not available |
Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women. Cancer epidemiology 2013 Oct 37 (5): 639-46. Zheng Liyuan, Song Aiping, Ruan Yuan, Chen Lan, Liu Dongge, Li Xianghong, Guo Hongyan, Han Jiyuan, Li Yan, Tian Xinxia, Fang Weiga |
Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway. Oncotarget 2014 May 5 (10): 3029-38. Wheler Jennifer J, Moulder Stacy L, Naing Aung, Janku Filip, Piha-Paul Sarina A, Falchook Gerald S, Zinner Ralph, Tsimberidou Apostolia M, Fu Siqing, Hong David S, Atkins Johnique T, Yelensky Roman, Stephens Philip J, Kurzrock Razel |
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Ayhan Ayse, Kuhn Elisabetta, Wu Ren-Chin, Ogawa Hiroshi, Bahadirli-Talbott Asli, Mao Tsui-Lien, Sugimura Haruhiko, Shih Ie-Ming, Wang Tian- |
Biomarker Assessment of HR Deficiency, Tumor BRCA1/2 Mutations, and CCNE1 Copy Number in Ovarian Cancer: Associations with Clinical Outcome Following Platinum Monotherapy. Molecular cancer research : MCR 2018 Jul 16 (7): 1103-1111. Stronach Euan A, Paul James, Timms Kirsten M, Hughes Elisha, Brown Krystal, Neff Christopher, Perry Michael, Gutin Alexander, El-Bahrawy Mona, Steel Jennifer H, Liu Xinxue, Lewsley Liz-Anne, Siddiqui Nadeem, Gabra Hani, Lanchbury Jerry S, Brown Robe |
Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes. BMC cancer 2019 May 19 (1): 422. da Costa Alexandre A B A, do Canto Luisa M, Larsen Simon Jonas, Ribeiro Adriana Regina Gonçalves, Stecca Carlos Eduardo, Petersen Annabeth Høgh, Aagaard Mads M, de Brot Louise, Baumbach Jan, Baiocchi Glauco, Achatz Maria Isabel, Rogatto Silvia Regi |
Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse. American journal of obstetrics and gynecology 2019 5 221 (3): 245.e1-245.e15. Hollis Robert L, Carmichael Juliet, Meynert Alison M, Churchman Michael, Hallas-Potts Amelia, Rye Tzyvia, MacKean Melanie, Nussey Fiona, Semple Colin A, Herrington C Simon, Gourley Charl |
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss. Cancer biology & therapy 2019 11 21 (3): 197-202. Frisone Daniele, Charrier Melinda, Clement Sophie, Christinat Yann, Thouvenin Laure, Homicsko Krisztian, Michielin Olivier, Bodmer Alexandre, Chappuis Pierre O, McKee Thomas A, Tsantoulis Petr |
Genomic Profiling Comparison of Germline BRCA and Non-BRCA Carriers Reveals CCNE1 Amplification as a Risk Factor for Non-BRCA Carriers in Patients With Triple-Negative Breast Cancer. Frontiers in oncology 2020 11 10 583314. Huang Xin, Shao Di, Wu Huanwen, Zhu Changbin, Guo Dan, Zhou Yidong, Chen Chang, Lin Yan, Lu Tao, Zhao Bin, Wang Changjun, Sun Qia |
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. Cancer chemotherapy and pharmacology 2021 Jun . Sokolenko Anna P, Gorodnova Tatiana V, Bizin Ilya V, Kuligina Ekaterina Sh, Kotiv Khristina B, Romanko Alexandr A, Ermachenkova Tatiana I, Ivantsov Alexandr O, Preobrazhenskaya Elena V, Sokolova Tatiana N, Broyde Robert V, Imyanitov Evgeny |
Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women. Gynecologic oncology 2021 Mar . Filippova Olga T, Selenica Pier, Pareja Fresia, Vahdatinia Mahsa, Zhu Yingjie, Pei Xin, Riaz Nadeem, Long Roche Kara, Chi Dennis S, Abu-Rustum Nadeem R, Ellenson Lora H, Reis-Filho Jorge S, Zamarin Dmitriy, Weigelt Brit |
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients. Scientific reports 2021 Jan 11 (1): 387. Zhang Yingli, Shi Xiaoliang, Zhang Jiejie, Chen Xi, Zhang Peng, Liu Angen, Zhu T |
High cyclin E1 protein, but not gene amplification, is prognostic for basal-like breast cancer. The journal of pathology. Clinical research 2022 4 8 (4): 355-370. Aziz Diar, Lee Christine, Chin Venessa, Fernandez Kristine J, Phan Zoe, , , Waring Paul, Caldon C Elizabe |
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology 2023 6 . Todd M Bauer, Kathleen N Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Anna V Tinker, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne Jones, David Spigel, Siqing |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 2023 1 15 (1): . Peleg Hasson Shira, Hershkovitz Dov, Adar Lyri, Brezis Miriam, Shachar Eliya, Aks Rona, Galmor Lee, Raviv Yuval, Ben Neriah Shira, Merimsky Ofer, Sabo Edmond, Wolf Ido, Safra Tam |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: